Medication info
Telmisartan/Amlodipine 40/10 mg

Telmisartan/Amlodipine 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
White and light blue, oval-shaped, biconvex, double-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 202002375 · Approved 2020.04.05 · Insurance code 054800890

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see '3. Administration with Caution in the Following Patients'). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can be beneficial for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine. Proper blood pressure control is crucial as hypertension may increase the risk of cardiovascular diseases. This medication effectively lowers blood pressure by combining the effects of both drugs and helps to manage blood pressure stably according to the patient's health condition. Continuous use can reduce the risk of complications due to hypertension. Therefore, it is used effectively for blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. However, for patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see '3. Administration with Caution in the Following Patients'). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to patients allergic to the active ingredients, pregnant or breastfeeding women, or patients with severe liver or heart issues. Patients with compromised liver function, gastrointestinal disorders, reduced kidney function, and the elderly should exercise particular caution when using this medication. Side effects such as dizziness, swelling, and hypotension may occur; consult a doctor if symptoms are severe. Check conditions carefully before use in cases of hypotension or dehydration, as blood pressure could fall too low. This medication may increase potassium levels, so caution is warranted when taken with potassium-rich drugs or supplements. Patients with reduced kidney function should regularly monitor kidney status and electrolyte levels through blood tests. Patients with heart disease should carefully observe their cardiac condition while taking this medication. Dizziness or drowsiness may occur while driving or operating machinery, so caution is needed. This medication may interact with other antihypertensives or certain drugs; inform the doctor or pharmacist of any medications being taken. Overdose may lead to hypotension, cardiac irregularities, or kidney dysfunction, so dosage must be strictly adhered to. Store away from children and ensure it is protected from moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • hepatic dysfunction
  • liver damage
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • kidney dysfunction
  • urinary diseases
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that protects it from light and air, at room temperature between 1°C to 30°C. Storing it this way helps maintain its effectiveness and prevents deterioration.

Appearance and packaging

Appearance

White and light blue, oval-shaped, biconvex, double-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.